There were 1,479 press releases posted in the last 24 hours and 447,679 in the last 365 days.

IRBM Science Park to explore development strategies for peptide-based vaccines in July

3rd Peptides Event

SMi Group reports (26.04.2016, London): IRBM Head of Peptide Chemistry presents strategies on developing vaccines for viral diseases.

This year’s agenda has been tailored for attendees to gain valuable insight into topics reflecting industry-specific innovations, particularly in pre-clinical formulation and novel technologies.
— SMi Group
LONDON, SELECT STATE/PROVINCE, UNITED KINGDOM, April 27, 2016 /EINPresswire.com/ -- With new developments for peptides therapeutics bursting into the clinic at a rapid rate, SMi's 3rd Peptides Conference and Exhibition returns to London on 6th & 7th July. Registration is live on the website.

This year’s agenda has been tailored so attendees can gain valuable insight into timely topics reflecting industry-specific challenges and innovations, particularly in pre-clinical formulation and novel technologies that facilitate the advancement of next generation peptides.

In line with this, SMi are proud to have Elisabetta Bianchi, Head of Peptide Chemistry at peptide discovery experts IRBM Science Park, as a featured speaker. She will be speaking on Day 2 of the conference about strategies on developing vaccines for viral diseases. Her presentation will cover:
• Identification of potentially protective epitopes
• Design and conjugation of conformationally constrained epitopes
• Strategies to enhance peptide immunogenicity

Other notable presentations include:
• New synthetic anti-tuberculosis cyclohexylgriselimycin more than 50 years after the isolation of the natural griselimycin – Sanofi
• MEDI0382 as a promising therapeutic lead for treatment of Type 2 Diabetes and obesity - MedImmune.
• The oral peptide delivery technology landscape - Ipsen
• Assessing immunogenicity in peptide development – Abzena
• CMC case study on process development, commercial manufacturing and quality control for generic peptide APIs – Bachem
• Purification of synthetic peptides by reversed phase chromatography with Sanofi-Aventis

and more. A complete list of speakers and their topics can be viewed on http://www.peptidesevent.com.

The event also offers two pre-conference workshops on the discovery, development and deployment of cyclic peptides, and exploring cell-penetrating peptides as a powerful new tool for cellular research.

For those interested to attend the event, an early bird discount of £300 applies to all bookings made by 29th April 2016. For more information and to register, visit http://www.peptidesevent.com/ein.

For tailored sponsorship and branding opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk. For media enquiries contact Honey de Gracia on +44 (0) 20 7827 6102 or email hdegracia@smi-online.co.uk

3rd Peptides Event
6-7 July 2016
London, UK
Event Website: www.peptidesevent.com/ein

------------------------- END --------------------------
About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Honey de Gracia
SMi Group Ltd
+44 (0)20 7827 6102
email us here